Subjects will self-administer the nasal spray placebo or starting dose of D500 AU/mL in each nostril under observation. If the challenge is positive by an increase in symptom score by greater than or equal to 3 from baseline; then PNIF and nasal secretion collection will be repeated after 15 minutes.